Scientists have co-developed the world’s first product-ready, lab-produced, recombinant snakebite antivenom that protects ...
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...
The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
Smithsonian Magazine on MSN
Horseshoe Crab Blood Has Long Helped Us Make Safe Medicines. Now, Alternatives That Spare the Ancient Creatures Might Be Breaking Through
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...
Thermo Fisher Scientific invests ₹160 crore to expand its Bengaluru R&D centre, enhancing research in infectious diseases and ...
In a significant regulatory move, the Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Drugs ...
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...
The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted ...
Scientists have used alpaca and llama antibodies to create a next-generation antivenom that protects against a whole family ...
Patients with stroke who receive intra-arterial thrombolysis after thrombectomy are more likely to achieve superior 90-day ...
The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback